Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study on Endometrial Immune Profile Changes After Autologous Intrauterine Platelet Rich Plasma (PRP) Treatment

NCT07535190 is registered in ClinicalTrials.gov with Nadezhda Women's Health Hospital as lead sponsor.

NCT NCT07535190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07535190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study on Endometrial Immune Profile Changes After Autologous Intrauterine Platelet Rich Plasma (PRP) Treatment
Lead sponsor
Nadezhda Women's Health Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
January 19, 2026
Completion date
June 30, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

female infertility, ivf patients